Rocket Pharmaceuticals, Inc.RCKTNASDAQ
Loading
Interest Income Over TimeContracting
Percentile Rank85
3Y CAGR+47.4%
5Y CAGR+42.1%
Studio
Year-over-Year Change

Income earned from interest-bearing assets

3Y CAGR
+47.4%/yr
vs +23.2%/yr prior
5Y CAGR
+42.1%/yr
Recent acceleration
Acceleration
+24.2pp
Accelerating
Percentile
P85
Within normal range
vs 5Y Ago
5.8x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$12.46M-31.6%
2024$18.22M+14.3%
2023$15.94M+309.8%
2022$3.89M+26.8%
2021$3.07M+42.7%
2020$2.15M-37.0%
2019$3.41M+102.0%
2018$1.69M+106.3%
2017$819000.00+84.9%
2016$443000.00-